Q32 Bio (QTTB) awards 37,500-share PSU-linked grant to its CSO
Rhea-AI Filing Summary
Q32 Bio Inc. reported that Chief Scientific Officer Shelia M. Violette acquired 37,500 shares of common stock on July 16, 2026 from the vesting of performance-based restricted stock units tied to a financing of at least $100,000,000 in gross proceeds. These PSUs are also subject to a time-based condition and will vest in equal quarterly installments over three years from July 1, 2026, contingent on her continued service. Following this award, she holds 130,569 shares directly and 36,277 shares indirectly through Violette Holdings LLC, where she disclaims beneficial ownership beyond any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 37,500 shares
Net Buy
2 txns
Insider
Violette Shelia M.
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 37,500 | $0.00 | $0.00 |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 130,569 shares (Direct);
Common Stock — 36,277 shares (Indirect, By Violette Holdings LLC)
Footnotes (2)
- F1. Represents shares of Issuer common stock underlying performance-based restricted stock units ("PSUs") granted on July 6, 2026, which vested on July 16, 2026 with respect to a performance-based condition, upon achievement of the closing of a financing of at least $100,000,000 in gross proceeds on or before December 31, 2026. Such PSUs are also subject to a time-based condition, which provides that the PSUs shall vest in equal quarterly installments over three years from July 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Each PSU represents a contingent right to receive one share of Issuer common stock.
- F2. Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.
Key Figures
Share award: 37,500 shares
Direct holdings after transaction: 130,569 shares
Indirect holdings via Violette Holdings LLC: 36,277 shares
+2 more
5 metrics
Share award
37,500 shares
Common stock acquired on July 16, 2026 from PSU vesting
Direct holdings after transaction
130,569 shares
Direct Q32 Bio common stock held following the July 16, 2026 award
Indirect holdings via Violette Holdings LLC
36,277 shares
Indirectly held by Violette Holdings LLC with beneficial ownership disclaimed except for pecuniary interest
Financing performance threshold
$100,000,000 gross proceeds
Minimum financing size required for performance-based PSU vesting on or before December 31, 2026
PSU time-based vesting period
three years
PSUs vest in equal quarterly installments over three years from July 1, 2026
Key Terms
performance-based restricted stock units, time-based condition, gross proceeds, pecuniary interest, +1 more
5 terms
performance-based restricted stock units financial
"Represents shares of Issuer common stock underlying performance-based restricted stock units ("PSUs")"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
time-based condition financial
"Such PSUs are also subject to a time-based condition, which provides"
gross proceeds financial
"closing of a financing of at least $100,000,000 in gross proceeds on or before"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.
pecuniary interest regulatory
"disclaims beneficial ownership of these shares except to the extent of her pecuniary interest"
beneficial owner regulatory
"not be deemed an admission that she is the beneficial owner of such shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Q32 Bio (QTTB) disclose for Shelia M. Violette?
Q32 Bio disclosed that Chief Scientific Officer Shelia M. Violette acquired 37,500 shares of common stock on July 16, 2026. The shares arose from the vesting of performance-based restricted stock units as part of her equity compensation package.
What performance condition applies to the PSUs reported by Q32 Bio (QTTB)?
The PSUs vest based on closing a financing of at least $100,000,000 in gross proceeds on or before December 31, 2026. The filing states these PSUs vested on July 16, 2026 with respect to this performance-based condition once the financing requirement was achieved.
What is the time-based vesting schedule for the Q32 Bio (QTTB) PSUs?
Beyond the performance trigger, the PSUs are subject to a time-based condition and vest in equal quarterly installments over three years from July 1, 2026. Continued service to Q32 Bio through each vesting date is required for the remaining installments.